13-Feb-2026
Lifeward Seeks Shareholder Backing for Oratech Deal and Lifeline Financing
TipRanks (Mon, 9-Feb 5:00 PM ET)
Lifeward Granted Nasdaq Extension to Regain Listing Compliance
TipRanks (Mon, 9-Feb 7:29 AM ET)
Lifeward Secures $47 Million Strategic Investment with Oramed to Expand into Biotech and MedTech
Market Chameleon (Tue, 13-Jan 5:33 AM ET)
Globe Newswire (Tue, 13-Jan 8:00 AM ET)
Oramed and Lifeward Announce Strategic Transaction
PRNewswire (Tue, 13-Jan 7:58 AM ET)
Lifeward Appoints Bob Marshall as Chairman of the Board
Globe Newswire (Fri, 19-Dec 4:05 PM ET)
Globe Newswire (Wed, 17-Dec 8:00 AM ET)
Globe Newswire (Wed, 3-Dec 8:00 AM ET)
Globe Newswire (Mon, 17-Nov 8:00 AM ET)
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Globe Newswire (Fri, 14-Nov 8:00 AM ET)
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Lifeward Ltd. - trades on the NASDAQ stock market under the symbol LFWD.
As of February 13, 2026, LFWD stock price was flat at $0.51 with 124,694 million shares trading.
LFWD has a beta of 1.01, meaning it tends to be more sensitive to market movements. LFWD has a correlation of 0.03 to the broad based SPY ETF.
LFWD has a market cap of $9.34 million. This is considered a Sub-Micro Cap stock.
Last quarter Lifeward Ltd. - reported $6 million in Revenue and -$.19 earnings per share. This fell short of revenue expectation by $-116,000 and missed earnings estimates by -$.03.
LFWD has underperformed the market in the last year with a price return of -74.1% while the SPY ETF gained +13.0%. LFWD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.0% and -15.6%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
LFWD support price is $.49 and resistance is $.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFWD shares will trade within this expected range on the day.